{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:32:22Z","timestamp":1753893142385,"version":"3.41.2"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To examine body weight change in women undergoing <jats:italic>in vitro<\/jats:italic> fertilization and embryo transfer (IVF-ET) using antagonist protocol after up to three treatment cycles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective cohort study among IVF patients treated between 2018 and 2019. Each patient underwent weight measurement three times during the treatment cycle: before treatment, at the beginning of the hormonal stimulation, and at the completion of the cycle, on the day of the pregnancy test. Data were also analyzed according to the body mass index (BMI) groups for normal weight, overweight, and obese patients. Finally, weight changes were recorded following altogether 519 treatment cycles, 240, 131, and 148 cycles, for normal weight, overweight, and obese patients, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The change in the patient's weight was clinically non-significant either during the waiting period or during gonadotropin administration, and overall, during the first, second, or third treatment cycles. The recorded mean total weight change of 0.26\u2009\u00b1\u20091.85, 0.4\u2009\u00b1\u20091.81, and 0.17\u2009\u00b1\u20091.7, after the first, second, or third treatment cycles, represent a change of 0.36%, 0.56%, and 0.23% of their initial weights, respectively. This change of less than 1% of the body weight falls short of the clinically significant weight gain of 5%\u20137%. Analyzing the data for the various BMI groups, the changes observed in body weight were under 1%, hence with no clinical significance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings of the study reject the myth that hormone therapy involves clinically significant weight gain, and this can lower the concerns of many patients who are candidates for treatment of assisted reproductive technology.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frph.2023.1327110","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T05:45:06Z","timestamp":1704692706000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Is there any truth in the myth that IVF treatments involve weight gain?"],"prefix":"10.3389","volume":"5","author":[{"given":"Bozhena","family":"Saar-Ryss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Shilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Friger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonti","family":"Grin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"Michailov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simion","family":"Meltcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Zaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Rabinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Lazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shevach","family":"Friedler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/14647273.2010.549161","article-title":"The impact of long down regulation in vitro fertilisation cycles on patients\u2019 weight","volume":"14","author":"Suthersan","year":"2011","journal-title":"Hum Fertil"},{"key":"B2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejogrb.2021.06.029","article-title":"Does the controlled ovarian stimulation increase the weight of women undergoing IVF treatment?","volume":"263","author":"Tso","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2014-3421","article-title":"Clinical review drugs commonly associated with weight change: a systematic review and meta-analysis","volume":"100","author":"Domecq","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5152\/jtgga.2015.15232","article-title":"Impact of obesity on infertility in women","volume":"16","author":"Da\u011f","year":"2015","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/humupd\/dmz011","article-title":"Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis","volume":"25","author":"Sermondade","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0974-1208.86080","article-title":"Ovarian hyperstimulation syndrome","volume":"4","author":"Kumar","year":"2011","journal-title":"J Hum Reprod Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.fertnstert.2009.07.1662","article-title":"The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome","volume":"94","author":"Grossman","year":"2010","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.fertnstert.2020.06.002","article-title":"Short-term weight change and live birth among women with unexplained infertility and polycystic ovary syndrome undergoing ovulation induction","volume":"114","author":"Vitek","year":"2020","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1093\/humrep\/deu223","article-title":"Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy","volume":"29","author":"J\u00e4rvel\u00e4","year":"2014","journal-title":"Hum Reprod"},{"key":"B11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1530\/JME-17-0036","article-title":"Serum estradiol levels in controlled ovarian stimulation directly affect the endometrium","volume":"59","author":"Ullah","year":"2017","journal-title":"J Mol Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","article-title":"Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis","volume":"19","author":"Barton","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"B13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.joca.2012.09.010","article-title":"Clinically important body weight gain following total hip arthroplasty: a cohort study with 5-year follow-up","volume":"21","author":"Riddle","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"B14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10815-022-02444-w","article-title":"Weight gain after in vitro fertilization: a potential consequence of controlled ovarian stimulation","volume":"39","author":"Bajaj","year":"2022","journal-title":"J Assist Reprod Genet"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2023.1327110\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T05:45:08Z","timestamp":1704692708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2023.1327110\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":14,"alternative-id":["10.3389\/frph.2023.1327110"],"URL":"https:\/\/doi.org\/10.3389\/frph.2023.1327110","relation":{},"ISSN":["2673-3153"],"issn-type":[{"type":"electronic","value":"2673-3153"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1327110"}}